CYP
Target: $1.30 - $1.50
A MEMS tech company at a very stage was valued at well above $250m at one point, why the World-First MSC breakthrough should not be valued at $250m? or even half of $250m?
CYP is not really hyped at current price, it will retrace after hit high, but it not like some other trading stocks which fundamentals are very weak.
Cynata achieves world-first MSC breakthrough
By Dylan Bushell-Embling | Posted in Stem cells on 19 February, 2015
Cynata Therapeutics (ASX:CYP) has achieved a world-first breakthrough of manufacturing mesenchymal stromal cells (MSCs) to therapeutic standards using induced pluripotent stem cells.
- See more at: http://lifescientist.com.au/content...c-breakthrough-860922300#sthash.L2G8Jf6e.dpuf
- Forums
- ASX - Day Trading
- Daytrading Feb 20 Morning
Daytrading Feb 20 Morning, page-2
-
- There are more pages in this discussion • 323 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online